Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

VPT.V Relative to the S&P 500

VPT.V Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Ventripoint Diagnostics Ltd. (TSXV:VPT.V) seasonal charts above shows that a Buy Date of November 25 and a Sell Date of March 31 has resulted in a geometric average return of 45.44% above the benchmark rate of the S&P 500 Total Return Index over the past 17 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 17 years by an average of 54.09% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

VentriPoint Diagnostics Ltd. is a medical device company, which engages in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its Ventripoint Medical System produces critical heart information by processing standard information received from existing medical imaging equipment with its patented and proprietary methods incorporating Knowledge Based Reconstruction algorithms and proprietary cardiac databases. The company was founded by Joseph Ashley and Florence H. Sheehan on May 4, 2005 and is headquartered in Toronto, Canada.

To download VPT.V seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: VPT.V